Published in Cell on March 23, 2007
ARDB--Antibiotic Resistance Genes Database. Nucleic Acids Res (2008) 7.82
Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev (2010) 7.35
Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev (2008) 5.97
Functional characterization of the antibiotic resistance reservoir in the human microflora. Science (2009) 4.78
The biology and future prospects of antivirulence therapies. Nat Rev Microbiol (2008) 3.83
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
Platforms for antibiotic discovery. Nat Rev Drug Discov (2013) 3.66
Aminoglycoside modifying enzymes. Drug Resist Updat (2010) 3.19
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev (2011) 2.46
Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat Rev Microbiol (2013) 2.22
Antibiotics: Recover the lost art of drug discovery. Nature (2012) 2.19
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol (2008) 2.01
The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc Biol Sci (2009) 1.94
Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol (2009) 1.92
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother (2010) 1.78
Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev (2015) 1.69
Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol (2008) 1.61
Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol (2013) 1.58
Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. Antimicrob Agents Chemother (2008) 1.57
Plasmid metagenome reveals high levels of antibiotic resistance genes and mobile genetic elements in activated sludge. PLoS One (2011) 1.41
The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. BMC Infect Dis (2017) 1.40
Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Curr Opin Chem Biol (2008) 1.34
Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis. J Bacteriol (2009) 1.33
Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care (2015) 1.30
Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol (2015) 1.29
On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proc Natl Acad Sci U S A (2012) 1.28
Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS One (2013) 1.27
Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity. Chem Commun (Camb) (2011) 1.26
Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli. Antimicrob Agents Chemother (2010) 1.24
Structural genomics and drug discovery for infectious diseases. Infect Disord Drug Targets (2009) 1.21
Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents. Antimicrob Agents Chemother (2011) 1.19
Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen. PLoS Genet (2008) 1.18
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18
Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS Pathog (2010) 1.18
Multidrug resistance: an emerging crisis. Interdiscip Perspect Infect Dis (2014) 1.17
Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nat Commun (2014) 1.16
Functional rotation of the transporter AcrB: insights into drug extrusion from simulations. PLoS Comput Biol (2010) 1.15
Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front Microbiol (2013) 1.12
Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution. Mol Biol Evol (2014) 1.08
Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr. Proc Natl Acad Sci U S A (2008) 1.08
Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano (2014) 1.05
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol (2012) 1.05
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci (2014) 1.05
Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa. PLoS One (2011) 1.03
Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2011) 1.03
Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. Nat Protoc (2013) 1.02
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J (2013) 1.01
Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother (2010) 1.01
Regulating toxin-antitoxin expression: controlled detonation of intracellular molecular timebombs. Toxins (Basel) (2014) 1.00
Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res (2013) 1.00
Positive epistasis between co-infecting plasmids promotes plasmid survival in bacterial populations. ISME J (2013) 0.99
A continuous fluorometric assay for the assessment of MazF ribonuclease activity. Anal Biochem (2007) 0.98
Could public restrooms be an environment for bacterial resistomes? PLoS One (2013) 0.98
Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. Proc Natl Acad Sci U S A (2013) 0.98
Influence of soil use on prevalence of tetracycline, streptomycin, and erythromycin resistance and associated resistance genes. Antimicrob Agents Chemother (2011) 0.96
Interactions between horizontally acquired genes create a fitness cost in Pseudomonas aeruginosa. Nat Commun (2015) 0.96
Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health (2015) 0.96
The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol Appl (2014) 0.95
Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat Commun (2014) 0.95
Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England. Ann Clin Microbiol Antimicrob (2010) 0.95
Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol Mol Biol Rev (2015) 0.95
Multidrug Efflux Pumps in Staphylococcus aureus: an Update. Open Microbiol J (2013) 0.95
Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species. Front Microbiol (2013) 0.95
Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol (2011) 0.94
KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance. Antimicrob Agents Chemother (2013) 0.94
Toxin-antitoxin genes of the Gram-positive pathogen Streptococcus pneumoniae: so few and yet so many. Microbiol Mol Biol Rev (2012) 0.94
Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol (2012) 0.94
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet (2015) 0.93
Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world. Front Microbiol (2013) 0.93
High-frequency transposition for determining antibacterial mode of action. Nat Chem Biol (2011) 0.92
Broad-host-range IncP-1 plasmids and their resistance potential. Front Microbiol (2013) 0.92
Bacterial Adaptation during Chronic Respiratory Infections. Pathogens (2015) 0.92
The rising threat of fungicide resistance in plant pathogenic fungi: Botrytis as a case study. J Chem Biol (2014) 0.91
IKKbeta/NF-kappaB and the miscreant macrophage. J Exp Med (2008) 0.91
The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. BMC Evol Biol (2013) 0.91
Functional metagenomics for the investigation of antibiotic resistance. Virulence (2014) 0.90
The antibiotic Furvina® targets the P-site of 30S ribosomal subunits and inhibits translation initiation displaying start codon bias. Nucleic Acids Res (2012) 0.90
A copper-responsive global repressor regulates expression of diverse membrane-associated transporters and bacterial drug resistance in mycobacteria. J Biol Chem (2012) 0.90
Application of metagenomics in the human gut microbiome. World J Gastroenterol (2015) 0.90
Tunable stochastic pulsing in the Escherichia coli multiple antibiotic resistance network from interlinked positive and negative feedback loops. PLoS Comput Biol (2013) 0.89
Antibiotic adjuvants: identification and clinical use. Microb Biotechnol (2013) 0.89
Structures of BmrR-drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion. J Biol Chem (2008) 0.89
Genotyping as a tool for antibiotic resistance surveillance of Neisseria gonorrhoeae in New Caledonia: evidence of a novel genotype associated with reduced penicillin susceptibility. Antimicrob Agents Chemother (2008) 0.89
Comparative genomic analysis of four representative plant growth-promoting rhizobacteria in Pseudomonas. BMC Genomics (2013) 0.89
Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis (2013) 0.89
Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLoS One (2014) 0.88
Nanomedicine in the Management of Microbial Infection - Overview and Perspectives. Nano Today (2014) 0.87
The aminoglycoside antibiotic kanamycin damages DNA bases in Escherichia coli: caffeine potentiates the DNA-damaging effects of kanamycin while suppressing cell killing by ciprofloxacin in Escherichia coli and Bacillus anthracis. Antimicrob Agents Chemother (2012) 0.87
The outer membrane protein TolC is required for phytoalexin resistance and virulence of the fire blight pathogen Erwinia amylovora. Microb Biotechnol (2009) 0.86
Identifying co-targets to fight drug resistance based on a random walk model. BMC Syst Biol (2012) 0.86
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. J Bacteriol (2009) 0.85
Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification. Genome Biol Evol (2014) 0.85
Environmental dissemination of antibiotic resistance genes and correlation to anthropogenic contamination with antibiotics. Infect Ecol Epidemiol (2015) 0.85
Transcriptional cross talk within the mar-sox-rob regulon in Escherichia coli is limited to the rob and marRAB operons. J Bacteriol (2012) 0.84
New approaches to filling the gap in tuberculosis drug discovery. PLoS Med (2007) 0.84
Herbicide cycling has diverse effects on evolution of resistance in Chlamydomonas reinhardtii. Evol Appl (2012) 0.84
Bacteria, phages and septicemia. PLoS One (2007) 0.84
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis (2009) 4.87
Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev (2011) 4.15
Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescens. Genome Biol (2009) 3.63
Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev (2011) 2.96
Public health and biosecurity. Adaptations of avian flu virus are a cause for concern. Science (2012) 2.52
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
An open letter to Elias Zerhouni. Science (2005) 2.19
Consumer antibacterial soaps: effective or just risky? Clin Infect Dis (2007) 1.70
Policy: Adaptations of avian flu virus are a cause for concern. Nature (2012) 1.54
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrob Agents Chemother (2013) 1.39
The history of the tetracyclines. Ann N Y Acad Sci (2011) 1.28
Transcriptional and antagonistic responses of Pseudomonas fluorescens Pf0-1 to phylogenetically different bacterial competitors. ISME J (2011) 1.27
Use of in vivo expression technology to identify genes important in growth and survival of Pseudomonas fluorescens Pf0-1 in soil: discovery of expressed sequences with novel genetic organization. J Bacteriol (2004) 1.24
Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli. Antimicrob Agents Chemother (2010) 1.24
Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors. Bioorg Med Chem Lett (2007) 1.20
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology (2006) 1.15
Importance of positioning for microbial evolution. Proc Natl Acad Sci U S A (2014) 1.13
Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis (2005) 1.10
Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother (2004) 1.09
Role of the multidrug resistance regulator MarA in global regulation of the hdeAB acid resistance operon in Escherichia coli. J Bacteriol (2007) 1.07
Overlapping protein-encoding genes in Pseudomonas fluorescens Pf0-1. PLoS Genet (2008) 1.06
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun (2010) 1.06
Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J Bacteriol (2006) 1.05
Activation of the Escherichia coli nfnB gene by MarA through a highly divergent marbox in a class II promoter. Mol Microbiol (2002) 1.04
Genetic analysis of the AdnA regulon in Pseudomonas fluorescens: nonessential role of flagella in adhesion to sand and biofilm formation. J Bacteriol (2003) 1.03
MarA-mediated transcriptional repression of the rob promoter. J Biol Chem (2006) 1.02
The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA. J Biol Chem (2003) 1.00
IVET experiments in Pseudomonas fluorescens reveal cryptic promoters at loci associated with recognizable overlapping genes. Microbiology (2004) 1.00
N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents. J Med Chem (2009) 1.00
Use of antibacterial consumer products containing quaternary ammonium compounds and drug resistance in the community. J Antimicrob Chemother (2008) 0.99
Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions. J Org Chem (2003) 0.98
Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology (2009) 0.96
Antibacterial cleaning products and drug resistance. Emerg Infect Dis (2005) 0.94
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications. Antimicrob Agents Chemother (2007) 0.94
Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR. Mol Microbiol (2007) 0.94
N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability. Bioorg Med Chem Lett (2010) 0.93
Proteomic detection of non-annotated protein-coding genes in Pseudomonas fluorescens Pf0-1. PLoS One (2009) 0.91
Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China. Antimicrob Agents Chemother (2013) 0.89
Tet protein hybrids. Antimicrob Agents Chemother (2005) 0.89
Requirement of polyphosphate by Pseudomonas fluorescens Pf0-1 for competitive fitness and heat tolerance in laboratory media and sterile soil. Appl Environ Microbiol (2009) 0.88
The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli. J Bacteriol (2003) 0.88
Mutational analysis of the multiple-antibiotic resistance regulator MarR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains. J Bacteriol (2013) 0.86
Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrob Agents Chemother (2011) 0.86
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli. Antimicrob Agents Chemother (2009) 0.85
MarA-like regulator of multidrug resistance in Yersinia pestis. Antimicrob Agents Chemother (2006) 0.85
Regulation of acrAB expression by cellular metabolites in Escherichia coli. J Antimicrob Chemother (2013) 0.84
The marC gene of Escherichia coli is not involved in multiple antibiotic resistance. Antimicrob Agents Chemother (2007) 0.83
Evidence that regulatory protein MarA of Escherichia coli represses rob by steric hindrance. J Bacteriol (2010) 0.83
Antimicrobial consumer products: where's the benefit? What's the risk? Arch Dermatol (2002) 0.83
The 216-bp marB gene of the marRAB operon in Escherichia coli encodes a periplasmic protein which reduces the transcription rate of marA. FEMS Microbiol Lett (2013) 0.83
SoxS increases the expression of the zinc uptake system ZnuACB in an Escherichia coli murine pyelonephritis model. J Bacteriol (2011) 0.82
Substitutions in the interdomain loop of the Tn10 TetA efflux transporter alter tetracycline resistance and substrate specificity. Microbiology (2005) 0.82
Second-site suppressor mutations for the serine 202 to phenylalanine substitution within the interdomain loop of the tetracycline efflux protein Tet(C). J Biol Chem (2003) 0.81
Increased fitness of Pseudomonas fluorescens Pf0-1 leucine auxotrophs in soil. Appl Environ Microbiol (2008) 0.81
Pleiotropic effects of GacA on Pseudomonas fluorescens Pf0-1 in vitro and in soil. Appl Environ Microbiol (2013) 0.80
Use of functional interactions with MarA to discover chromosomal genes affecting antibiotic susceptibility in Escherichia coli. Int J Antimicrob Agents (2010) 0.80
The periplasmic protein MppA is not involved in regulation of marA in Escherichia coli. Antimicrob Agents Chemother (2011) 0.79
The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents. Curr Microbiol (2012) 0.79
Fe(2+)-tetracycline-mediated cleavage of the Tn10 tetracycline efflux protein TetA reveals a substrate binding site near glutamine 225 in transmembrane helix 7. J Bacteriol (2002) 0.79
Novel genes involved in Pseudomonas fluorescens Pf0-1 motility and biofilm formation. Appl Environ Microbiol (2012) 0.79
Retracted GyrA interacts with MarR to reduce repression of the marRAB operon in Escherichia coli. J Bacteriol (2009) 0.78
Regulation of polyphosphate kinase production by antisense RNA in Pseudomonas fluorescens Pf0-1. Appl Environ Microbiol (2012) 0.78
Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis. Infect Immun (2009) 0.77
Genome size and antibiotic resistance. Antimicrob Agents Chemother (2008) 0.77
Bacteremia among Kenyan Children. N Engl J Med (2005) 0.75
Mechanisms for resistance in soil. Science (2006) 0.75
Amino acid residues involved in inactivation of the Escherichia coli multidrug resistance repressor MarR by salicylate, 2,4-dinitrophenol, and plumbagin. FEMS Microbiol Lett (2013) 0.75
The contribution of PmrAB to the virulence of a clinical isolate of Escherichia coli. Virulence (2013) 0.75
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate. Antimicrob Agents Chemother (2007) 0.75
Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors. Int J Oncol (2006) 0.75
The misuse of antibiotics. Med Ethics (Burlingt Mass) (2004) 0.75
Toward optimal health: the experts discuss antibiotic therapy in primary care. Interview by Jodi Godfrey Meisler. J Womens Health Gend Based Med (2002) 0.75